Primo Chemicals Limited (NSE:PRIMO)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	6,684	5,135	8,259	19,613	20,890	2,779
Market Cap Growth	-37.82%	-37.82%	-57.89%	-6.11%	651.62%	261.21%
Enterprise Value	8,290	6,770	9,832	20,105	20,993	2,997
PE Ratio	187.76	144.26	-	14.28	35.28	33.74
PS Ratio	1.16	0.89	2.08	2.77	4.60	1.23
PB Ratio	1.71	1.31	2.13	4.76	7.56	2.88
P/TBV Ratio	1.71	1.32	2.13	4.76	7.56	2.88
P/FCF Ratio	27.53	21.15	-	-	-	9.96
P/OCF Ratio	10.37	7.97	60.41	13.11	29.75	5.27
EV/Sales Ratio	1.44	1.17	2.48	2.84	4.62	1.32
EV/EBITDA Ratio	9.49	7.85	47.74	9.30	20.98	7.55
EV/EBIT Ratio	21.08	17.76	-	10.38	24.99	12.38
EV/FCF Ratio	34.14	27.88	-	-	-	10.74
Debt / Equity Ratio	0.43	0.43	0.46	0.35	0.22	0.01
Debt / EBITDA Ratio	1.96	1.96	8.44	0.67	0.61	0.02
Debt / FCF Ratio	6.96	6.96	-	-	-	0.02
Asset Turnover	0.79	0.79	0.55	1.17	1.25	0.96
Inventory Turnover	12.65	12.65	13.77	20.16	21.62	24.78
Quick Ratio	0.21	0.21	0.39	0.68	0.61	0.25
Current Ratio	0.61	0.61	0.53	0.83	0.76	0.31
Return on Equity (ROE)	0.92%	0.92%	-6.34%	39.90%	31.75%	9.86%
Return on Assets (ROA)	3.28%	3.28%	-1.34%	20.02%	14.50%	6.39%
Return on Capital (ROIC)	4.24%	4.24%	-1.73%	27.07%	24.15%	15.17%
Return on Capital Employed (ROCE)	7.60%	7.60%	-	34.40%	24.20%	20.90%
Earnings Yield	0.53%	0.69%	-3.07%	7.00%	2.83%	2.96%
FCF Yield	3.63%	4.73%	-6.53%	-1.67%	-4.15%	10.04%
Buyback Yield / Dilution	2.07%	2.07%	-	-6.98%	-63.25%	-2.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.